Loading organizations...
Research and development of antiviral drugs.
Nanjing Orui Pharmaceutical has raised $14.1M across 1 funding round.
Nanjing Orui Pharmaceutical has raised $14.1M in total across 1 funding round.
Nanjing Orui Pharmaceutical has raised $14.1M in total across 1 funding round.
Nanjing Orui Pharmaceutical's investors include Hermed Capital.
Nanjing Orui Pharmaceutical has raised $14.1M across 1 funding round. Most recently, it raised $14.1M Pre-Series A in May 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 7, 2020 | $14.1M Pre-Series A | Hermed Capital |